跳至主要内容
临床试验/CTRI/2020/02/023488
CTRI/2020/02/023488尚未招募未知

A comparative study of efficacy and safety of Sacubitril/ Valsartan combination with Ramipril on left ventricular ejection fraction in post coronary artery bypass grafting (CABG) patients.

Soumitra Mandal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • I.Patients planning for CABG
  • II.Age in between 30 to 70 years.
  • III.New York Heart association (NYHA) functional class II-IV symptoms for heart failure.
  • IV.Ejection fraction of 40% or less.

排除标准

  • I.Symptomatic hypotension (Systolic blood pressure < 100 mm hg).
  • II.Estimated glomerular filtration rate <30 ml/min/1.73 m2 [Gfr estimated by MDRD study equation]
  • III.Hypersensitivity to study medication.
  • IV.Any history of angioedema.
  • V.Concomitant use with any drug formulation containing an angiotensin-converting enzyme inhibitor.

研究者

发起方
Soumitra Mandal

相似试验

Effect of Sacubitril/ Valsartan and ramipril on... | 临床试验